Percutaneous coronary interventions with the Absorb Bioresorbable vascular scaffold in real life: 1-year results from the FRANCE ABSORB registry-Reference-Cited by-同舟云学术

Percutaneous coronary interventions with the Absorb Bioresorbable vascular scaffold in real life: 1-year results from the FRANCE ABSORB registry

Published:2019-02 Issue:2 Volume:112 Page:113-123
ISSN:1875-2136
Container-title:Archives of Cardiovascular Diseases
language:en
Short-container-title:Archives of Cardiovascular Diseases

Author:

Cayla Guillaume^ORCID,Koning René,Fajadet Jean,Sainsous Joel,Carrié Didier,Elhadad Simon,Tarragano Francois,Lefévre Thierry^ORCID,Ranc Sylvain,Ghostine Said,Garot Philippe,Marco Frédéric,Maillard Luc^ORCID,Motreff Pascal,Le Breton Hervé

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Reference26 articles.

1. From metallic cages to transient bioresorbable scaffolds: change in paradigm of coronary revascularization in the upcoming decade?;Serruys;Eur Heart J,2012

2. Bioresorbable vascular scaffolds: time to absorb past lessons or fade away?;de Pommereau;Arch Cardiovasc Dis,2018

3. Bioresorbable scaffold - A magic bullet for the treatment of coronary artery disease?;Brie;Int J Cardiol,2016

4. Everolimus-eluting bioresorbable scaffolds for coronary artery disease;Ellis;N Engl J Med,2015

5. Stent thrombosis with drug-eluting stents and bioresorbable scaffolds: evidence from a network meta-analysis of 147 trials;Kang;JACC Cardiovasc Interv,2016

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Five-year clinical outcomes using the bioresorbable vascular scaffold: Insights from the FRANCE ABSORB registry;Archives of Cardiovascular Diseases;2022-10

2. Bioresorbable vascular scaffolds in the routine clinical practice: long-term results;REC: interventional cardiology (English Edition);2021-07-16

3. Three‐year clinical outcomes with the ABSORB bioresorbable vascular scaffold in real life: Insights from the France ABSORB registry;Catheterization and Cardiovascular Interventions;2020-11-19

4. The Future of Cardiovascular Stents: Bioresorbable and Integrated Biosensor Technology;Advanced Science;2019-08-19

5. Everolimus-eluting bioresorbable scaffolds for treatment of coronary artery disease in patients with diabetes mellitus: the midterm follow-up of the prospective ABSORB DM Benelux study;Cardiovascular Diabetology;2019-03-09